Angela Hildreth
Finance Director, Chief Operating Officer and Company Secretary
Current roles
Angela Hildreth leads the Group’s finance, HR and IT functions, drives commercial and financial strategy, ensures its compliance procedures and is a principal contact for shareholder and investor relations matters.
Past roles
Senior financial roles in a diverse range of industries, including seven years as UK Finance Director at Shield Therapeutics plc (quoted on AIM). She was also an Independent Non-Executive Director and Chair of the Audit Committee at AIM-listed Aptamer plc.
Brings to the Board
Over 15 years’ strategic and operational financial experience of developing and commercialising pharmaceutical products.
Ken James
Executive Director and Head of R&D
Current roles
Ken James is the Head of R&D. He oversees the development, regulatory, quality and manufacturing strategies for the Group’s existing pipeline and the evaluation of early stage pipeline opportunities. He is also an Executive Director.
Past roles
Senior Vice President of Research and Development for GlaxoSmithKline Worldwide Consumer Healthcare, having worked in the UK and the United States.
Brings to the Board
Over 40 years’ experience in the research, development and commercialisation of consumer healthcare products.
Andrew Unitt
Senior Independent Non-Executive Director
Current Roles
Andrew Unitt is an Independent Non-Executive Director and Chair of the Audit Committee. He is also a member of the Remuneration Committee and the Nominations Committee.
Past Roles
Chief Financial Officer at the University of Nottingham until 2016. Andrew spent eleven years at Boots plc, where he was Managing Director and Finance Director for four years of Boots Healthcare International, its over the counter medicines business.
Brings to the Board
Over 20 years of experience as a Finance Director in a wide range of industries with strong financial experience and OTC market expertise.
Roy Davis
Independent Non-Executive Director
Current Roles
Roy Davis is an Independent Non-Executive Director and Chair of the Remuneration Committee. He is a member of the Audit Committee and the Nominations Committee. He is also a Non-Executive Chair at Inspiration Healthcare Group plc, Foster and Freeman (the trading name of the Galton group of companies) and Lunglife AI plc.
Past Roles
Leadership positions at a number of publicly quoted med tech companies, including CEO of Optos plc and Gyrus Group plc and Non-Executive Chair at Medica Group plc.
Brings to the Board
Over 35 years of commercial experience including in medical devices companies and strategic consulting and has a proven track record of successfully scaling companies and delivering substantial value for shareholders.
Harmesh Suniara
Non-Executive Director
Current Roles
Harmesh Suniara is a Non-Executive Director. He is a Portfolio Manager at Lombard Odier Asset Management (Europe) Limited. He is also a Non-Executive Director at C4X Discovery, IQE plc and Actual Experience plc.
Past Roles
Investment Manager at Henderson Volantis Capital and Gartmore Investment Management.
Brings to the Board
Over 15 years' experience of working in investment management with a particular focus on UK small and mid-cap equities.